In our base case, a vaccine becomes available in the first half of 2021. However, of equal importance is the vaccine being sufficiently available, widely distributed and broadly accepted. We see some hiccups and setbacks in the process.
Our bull case sees multiple effective vaccines arriving earlier. Logistical challenges in vaccine distribution are dealt with effectively, and the economy is freed from the pendulum swing between lockdowns and re-openings. Here we see room for Keynes’ animal spirits.
This page is intended for US prospects, clients and investors only and includes information about the capabilities, staffing and history of RIAM US and its participating affiliates, which may include information on strategies not yet available in the US. SEC regulations are applicable only to clients, prospects and investors of RIAM US. Robeco BV, Robeco HK and Robeco SH are considered a “participating affiliate” of RIAM US and some of their employees are “associated persons” of RIAM US as per relevant SEC no-action guidance. Employees identified as associated persons of RIAM US perform activities directly or indirectly related to the investment advisory services provided by RIAM US. In those situations, these individuals are deemed to be acting on behalf of IUAM, a US SEC registered investment adviser.By clicking I agree, I confirm that I have read and understood the above.